Investors Snag ALNY Even Cheaper Than Its Secondary Stock Offering
December 07, 2017 at 10:04 AM EST
Looking back to 24 days ago, Alnylam Pharmaceuticals Inc (ALNY) priced a 5,600,000 share secondary stock offering at $125.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..